The Breast Cancer Core Needle Biopsy Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Others), By End-user (Biopharmaceutical Companies Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes).
The Breast Cancer Core Needle Biopsy Market is witnessing significant growth, driven by the increasing prevalence of breast cancer and the shift towards minimally invasive diagnostic procedures. Core needle biopsy is a key diagnostic technique for breast cancer, providing a more targeted approach to obtaining tissue samples for analysis. This market encompasses core needle biopsy devices, guidance systems, and related consumables. Manufacturers are focusing on the development of advanced biopsy systems with enhanced accuracy and patient comfort. With the growing emphasis on early cancer detection and personalized treatment strategies, the Breast Cancer Core Needle Biopsy Market is poised for sustained expansion, playing a crucial role in improving diagnostic accuracy and treatment planning.
The most prominent trend in the Breast Cancer Core Needle Biopsy Market is the widespread adoption of minimally invasive breast biopsy techniques for improved diagnostics. Clinicians are increasingly favoring core needle biopsy procedures over traditional surgical biopsies due to their minimally invasive nature, reduced patient discomfort, and faster recovery times. This trend involves the use of specialized core needle biopsy devices that allow for the precise sampling of breast tissue, aiding in the accurate diagnosis of breast cancer. The Breast Cancer Core Needle Biopsy Market is witnessing a shift towards these less invasive techniques, offering a balance between diagnostic accuracy and patient-centric care.
A major driver propelling the Breast Cancer Core Needle Biopsy Market is the growing emphasis on early detection and screening programs. As awareness about breast cancer increases, there is a heightened focus on routine screening to detect abnormalities at an early stage, when treatment outcomes are often more favorable. Core needle biopsy procedures play a crucial role in the diagnostic pathway by providing accurate tissue samples for pathological examination. The market is driven by the global efforts to improve breast cancer outcomes through early detection initiatives, driving the demand for core needle biopsy procedures as a key component of diagnostic protocols.
An emerging opportunity in the Breast Cancer Core Needle Biopsy Market lies in the advancements in imaging guidance technologies for biopsy procedures. Market players have the potential to innovate and integrate advanced imaging modalities, such as ultrasound, stereotactic mammography, or magnetic resonance imaging (MRI), to enhance the precision and accuracy of core needle biopsy procedures. This opportunity involves the development of biopsy systems that offer real-time imaging guidance, enabling clinicians to target lesions with greater accuracy and improve the diagnostic yield. The integration of advanced imaging technologies presents a valuable opportunity for companies to contribute to the refinement of breast cancer diagnostics, providing clinicians with enhanced tools for more accurate and efficient core needle biopsy procedures. Seizing this opportunity allows companies to stay at the forefront of technological advancements in breast cancer diagnostics and patient care.
By Technology
By End-User
By Region
*List not exhaustuive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Breast Cancer Core Needle Biopsy Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Breast Cancer Core Needle Biopsy Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 INTRODUCTION TO 2024 Breast Cancer Core Needle Biopsy Markets
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 EXECUTIVE SUMMARY
3.1 Global Breast Cancer Core Needle Biopsy Market Size Outlook, $ Million, 2021 to 2030
3.2 Breast Cancer Core Needle Biopsy Market Outlook by Type, $ Million, 2021 to 2030
3.3 Breast Cancer Core Needle Biopsy Market Outlook by Product, $ Million, 2021 to 2030
3.4 Breast Cancer Core Needle Biopsy Market Outlook by Application, $ Million, 2021 to 2030
3.5 Breast Cancer Core Needle Biopsy Market Outlook by Key Countries, $ Million, 2021 to 2030
4 MARKET DYNAMICS
4.1 Key Driving Forces of Breast Cancer Core Needle Biopsy Market Industry
4.2 Key Market Trends in Breast Cancer Core Needle Biopsy Market Industry
4.3 Potential Opportunities in Breast Cancer Core Needle Biopsy Market Industry
4.4 Key Challenges in Breast Cancer Core Needle Biopsy Market Industry
5 MARKET FACTOR ANALYSIS
5.1 Competitive Landscape
5.1.1 Global Breast Cancer Core Needle Biopsy Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 GROWTH OUTLOOK ACROSS SCENARIOS
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 GLOBAL Breast Cancer Core Needle Biopsy Market OUTLOOK BY SEGMENTS
7.1 Breast Cancer Core Needle Biopsy Market Outlook by Segments
By Technology
MRI-Based Breast Biopsy
Ultrasound-Based Breast Biopsy
Mammography-Based (Stereotactic) Breast Biopsy
CT-Based Breast Biopsy
Others
By End-User
Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology companies
Academic & Research Institutes
8 NORTH AMERICA Breast Cancer Core Needle Biopsy Market ANALYSIS AND OUTLOOK TO 2030
8.1 Introduction to North America Breast Cancer Core Needle Biopsy Markets in 2024
8.2 North America Breast Cancer Core Needle Biopsy Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Breast Cancer Core Needle Biopsy Market size Outlook by Segments, 2021-2030
By Technology
MRI-Based Breast Biopsy
Ultrasound-Based Breast Biopsy
Mammography-Based (Stereotactic) Breast Biopsy
CT-Based Breast Biopsy
Others
By End-User
Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology companies
Academic & Research Institutes
9 EUROPE Breast Cancer Core Needle Biopsy Market ANALYSIS AND OUTLOOK TO 2030
9.1 Introduction to Europe Breast Cancer Core Needle Biopsy Markets in 2024
9.2 Europe Breast Cancer Core Needle Biopsy Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Breast Cancer Core Needle Biopsy Market size Outlook by Segments, 2021-2030
By Technology
MRI-Based Breast Biopsy
Ultrasound-Based Breast Biopsy
Mammography-Based (Stereotactic) Breast Biopsy
CT-Based Breast Biopsy
Others
By End-User
Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology companies
Academic & Research Institutes
10 ASIA PACIFIC Breast Cancer Core Needle Biopsy Market ANALYSIS AND OUTLOOK TO 2030
10.1 Introduction to Asia Pacific Breast Cancer Core Needle Biopsy Markets in 2024
10.2 Asia Pacific Breast Cancer Core Needle Biopsy Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Breast Cancer Core Needle Biopsy Market size Outlook by Segments, 2021-2030
By Technology
MRI-Based Breast Biopsy
Ultrasound-Based Breast Biopsy
Mammography-Based (Stereotactic) Breast Biopsy
CT-Based Breast Biopsy
Others
By End-User
Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology companies
Academic & Research Institutes
11 SOUTH AMERICA Breast Cancer Core Needle Biopsy Market ANALYSIS AND OUTLOOK TO 2030
11.1 Introduction to South America Breast Cancer Core Needle Biopsy Markets in 2024
11.2 South America Breast Cancer Core Needle Biopsy Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Breast Cancer Core Needle Biopsy Market size Outlook by Segments, 2021-2030
By Technology
MRI-Based Breast Biopsy
Ultrasound-Based Breast Biopsy
Mammography-Based (Stereotactic) Breast Biopsy
CT-Based Breast Biopsy
Others
By End-User
Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology companies
Academic & Research Institutes
12 MIDDLE EAST AND AFRICA Breast Cancer Core Needle Biopsy Market ANALYSIS AND OUTLOOK TO 2030
12.1 Introduction to Middle East and Africa Breast Cancer Core Needle Biopsy Markets in 2024
12.2 Middle East and Africa Breast Cancer Core Needle Biopsy Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Breast Cancer Core Needle Biopsy Market size Outlook by Segments, 2021-2030
By Technology
MRI-Based Breast Biopsy
Ultrasound-Based Breast Biopsy
Mammography-Based (Stereotactic) Breast Biopsy
CT-Based Breast Biopsy
Others
By End-User
Biopharmaceutical Companies Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology companies
Academic & Research Institutes
13 COMPANY PROFILES
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Intact Medical Corporation
Ethicon Surgical Technologies
Gallini SRL
Leica Biosystems Nussloch GmbH
Hologic, Inc.
Argon Medical Devices
Encapsule Medical Devices LLC
Cook Medical Incorporated
Becton, Dickinson and Company
C.R. Bard, Inc.
14 APPENDIX
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Technology
By End-User
By Region
The global Breast Cancer Core Needle Biopsy Market is one of the lucrative growth markets, poised to register a 9.6 growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Intact Medical Corporation, Ethicon Surgical Technologies, Gallini SRL, Leica Biosystems Nussloch GmbH, Hologic, Inc., Argon Medical Devices, Encapsule Medical Devices LLC, Cook Medical Incorporated, Becton, Dickinson and Company, C.R. Bard, Inc.
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume